NURS 535 Practice –Module 7-Exam
with Verified Answers
A patient with type 1 diabetes reports taking propranolol for hypertension. What concern does
this information present for the provider?
a- using propranolol with insulin increases the risk of DKA
b-propranolol increases insulin requirements because of receptor blocking
c- the B-Blocker can mask s/s of hypoglycemia
d- the B-Blocker can cause insulin resistance - ✔✔C, β blockers can delay awareness of and
response to hypoglycemia by masking signs associated with stimulation of the sympathetic
nervous system (e.g., tachycardia, palpitations) that hypoglycemia normally causes.
Furthermore, β blockade impairs glycogenolysis, which is one means by which the body can
counteract a fall in blood glucose; β blockers, therefore, can worsen insulin-induced
hypoglycemia. Propranolol does not cause insulin resistance. The incidence of DKA is not
increased by concurrent use of propranolol and insulin. Insulin requirements are not increased
because of receptor blocking by propranolol.
An older adult patient with type 2 diabetes has a history of severe hypoglycemia. The patient's
partner asks the provider what A1c level they should strive to achieve. What guideline will the
prescriber provide?
A- between 6.5 and 7
b- below 8
c- between 7 and 8.5
d- below 7 - ✔✔B, For patients with a history of severe hypoglycemia and those with a limited
life expectancy or advanced micro- and macrovascular complications, the target A1c level
should be below 8.0. For most other patients with diabetes, the target is 7.0 and below.
A pregnant patient recently began treatment for hypothyroidism. What response will the
provider give when the patient shares that she does not want to take medications while she is
pregnant?
a- no danger to the fetus exists until the third trimester
with Verified Answers
A patient with type 1 diabetes reports taking propranolol for hypertension. What concern does
this information present for the provider?
a- using propranolol with insulin increases the risk of DKA
b-propranolol increases insulin requirements because of receptor blocking
c- the B-Blocker can mask s/s of hypoglycemia
d- the B-Blocker can cause insulin resistance - ✔✔C, β blockers can delay awareness of and
response to hypoglycemia by masking signs associated with stimulation of the sympathetic
nervous system (e.g., tachycardia, palpitations) that hypoglycemia normally causes.
Furthermore, β blockade impairs glycogenolysis, which is one means by which the body can
counteract a fall in blood glucose; β blockers, therefore, can worsen insulin-induced
hypoglycemia. Propranolol does not cause insulin resistance. The incidence of DKA is not
increased by concurrent use of propranolol and insulin. Insulin requirements are not increased
because of receptor blocking by propranolol.
An older adult patient with type 2 diabetes has a history of severe hypoglycemia. The patient's
partner asks the provider what A1c level they should strive to achieve. What guideline will the
prescriber provide?
A- between 6.5 and 7
b- below 8
c- between 7 and 8.5
d- below 7 - ✔✔B, For patients with a history of severe hypoglycemia and those with a limited
life expectancy or advanced micro- and macrovascular complications, the target A1c level
should be below 8.0. For most other patients with diabetes, the target is 7.0 and below.
A pregnant patient recently began treatment for hypothyroidism. What response will the
provider give when the patient shares that she does not want to take medications while she is
pregnant?
a- no danger to the fetus exists until the third trimester
